Hypertensive disorders of pregnancy and subsequent risk of solid cancer – a nationwide cohort study

ABSTRACT

Women with hypertensive disorders of pregnancy (HDP) have higher levels of anti-angiogenic growth factors during pregnancy than women with normotensive pregnancies. Since angiogenesis is necessary for solid cancer growth and spread, we hypothesized that women with a history of HDP might have a reduced risk of solid cancers (cancers other than lymphomas, hematologic cancers and non-melanoma skin cancers) later in life. In a register-based cohort study of 1.08 million women giving birth at least once between 1978 and 2011, we used Cox regression to estimate hazard ratios (HRs) comparing solid cancer rates for women with and without a history of HDP. In this cohort, 68,236 women (6.3%) had ≥1 pregnancy complicated by HDP and 42,236 women (3.9%) developed solid tumors during follow-up. A history of HDP was not associated with a clinically meaningful reduction in the overall rate of solid cancer (HR 0.96, 95% confidence interval [CI] 0.92-1.00), regardless of HDP severity or time since HDP, nor was there a general tendency towards reduced solid cancer rates across organ sites. A history of HDP was only significantly associated with decreased rates of breast and lung cancers, and with increased rates of endometrial and urinary tract cancers. Overall, our results do not support the hypothesis that women with a history of HDP have a reduced overall risk of solid cancer due to a persistent post-HDP anti-angiogenic state or an innate tendency toward anti-angiogenesis. Observed associations with specific cancers may instead be due to other pregnancy-related mechanisms or to residual/unmeasured confounding. This article is protected by copyright. All rights reserved.

from Cancer via ola Kala on Inoreader http://ift.tt/1QAU5s5
via IFTTT